Squawk on the Street Cooler Inflation, TikTok and Musk, Cramer Interviews Eli Lilly's CEO 1/14/25
Jan 14, 2025
David Ricks, CEO of Eli Lilly and Company, shares insights on the promising landscape for the company’s weight loss drugs. He discusses healthcare payment complexities and the shift in perception of obesity as a disease. The conversation also touches on the repercussions of inflation data on the market and Elon Musk's potential acquisition of TikTok, exploring the tech landscape's evolution. Amidst regulatory challenges, Ricks highlights the innovative strategies driving pharmaceutical growth, making for an engaging and informative discussion.
AI Snips
Chapters
Transcript
Episode notes
Market Reaction to PPI
- The December Producer Price Index (PPI) came in cooler than economists' forecasts, giving the bulls some relief.
- However, bond yields haven't decreased much, possibly due to uncertainty about the new administration's policies.
TikTok, Musk, and China
- Reports of Chinese officials considering Elon Musk acquiring TikTok's U.S. operations are denied by TikTok.
- David Faber's reporting suggests this scenario is unlikely, as China has instructed ByteDance not to sell if TikTok is banned.
Tesla's Price Hike
- Jim Cramer mentions Morgan Stanley raising Tesla's price target to $430 with a bull case of $800.
- This is based on the idea that Tesla is not just a car company, but an AI-driven technology company.